Adela Announces $48 Million In Financing And Leadership Addition To Advance Tissue-Agnostic Minimal Residual Disease (Mrd) Monitoring Product Portfolio Based On Genome-Wide Methylome Approach
Amount Raised
$48 Million
Round Type
Funding Round
Foster CityBiotechnologyInvestors
Description
Adela, Inc., an innovator in blood testing for minimal residual disease monitoring and early cancer detection through a genome-wide methylome approach, announced today the closing of $48 million in financing. In addition, the company announced that Lisa Alderson will join Adela as interim Chief Executive Officer (CEO), succeeding Dr. Scott Bratman. Dr
Quick answer
Adela raised $48 Million in a Funding Round round, dated September 25, 2023. Investors: RA Capital Management, Labcorp, Decheng Capital, Deerfield Management, Orbi Med and F Prime Capital. Adela is based in Foster City, California, United States.
- How much did Adela raise?
- Adela raised $48 Million in a Funding Round round on September 25, 2023.
- Who invested in Adela?
- RA Capital Management, Labcorp, Decheng Capital, Deerfield Management, Orbi Med and F Prime Capital are named as investors in this round.
- What does Adela do?
- Adela’s mission is to develop innovative and accessible technologies that harness biology and change the way we diagnose and treat disease. Adela’s genome-wide methylation enrichment technology was originally..
- Where is Adela based and how big is it?
- Adela is based in Foster City, California, United States. Fundz records about 27 employees.
- Who are the decision-makers at Adela?
- Fundz holds 2 contacts at Adela, including the Co-founder and Chief Medical Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Adela that raised within 45 days of this round, from Fundz verified event records.
- Trailhead Biosystems raised $3M on November 9, 2023.
- Nūmi (ex-MUMilk) raised $3.2M (Seed) on November 9, 2023.
- Vivalink raised an undisclosed amount (Funding Round) on November 9, 2023.
- SURGLASSES raised $6.5M (Funding Round) on November 9, 2023.
- Cromatic raised $5.3M (Seed) on November 9, 2023.
- Eikonoklastes Therapeutics raised $2M on November 9, 2023.
Who to call at Adela, and when
A new round usually means Adela is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Adela raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Adela, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Adela. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Adela raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Adela raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.